- Home
- GP vs LPCN Comparison
GP vs LPCN Comparison
Compare GP & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GP
- LPCN
- Stock Information
- Founded
- GP 2010
- LPCN 1997
- Country
- GP Canada
- LPCN United States
- Employees
- GP N/A
- LPCN N/A
- Industry
- GP Construction/Ag Equipment/Trucks
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- GP Consumer Discretionary
- LPCN Health Care
- Exchange
- GP Nasdaq
- LPCN Nasdaq
- Market Cap
- GP 33.1M
- LPCN 36.8M
- IPO Year
- GP 2020
- LPCN N/A
- Fundamental
- Price
- GP $0.82
- LPCN $5.00
- Analyst Decision
- GP Strong Buy
- LPCN Strong Buy
- Analyst Count
- GP 2
- LPCN 1
- Target Price
- GP $2.33
- LPCN $10.00
- AVG Volume (30 Days)
- GP 489.7K
- LPCN 26.8K
- Earning Date
- GP 11-14-2024
- LPCN 11-07-2024
- Dividend Yield
- GP N/A
- LPCN N/A
- EPS Growth
- GP N/A
- LPCN N/A
- EPS
- GP N/A
- LPCN N/A
- Revenue
- GP $21,595,069.00
- LPCN $7,922,926.00
- Revenue This Year
- GP N/A
- LPCN N/A
- Revenue Next Year
- GP $109.55
- LPCN N/A
- P/E Ratio
- GP N/A
- LPCN N/A
- Revenue Growth
- GP N/A
- LPCN N/A
- 52 Week Low
- GP $0.70
- LPCN $2.38
- 52 Week High
- GP $3.42
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- GP 36.60
- LPCN 46.99
- Support Level
- GP $0.78
- LPCN $4.64
- Resistance Level
- GP $0.96
- LPCN $5.40
- Average True Range (ATR)
- GP 0.05
- LPCN 0.54
- MACD
- GP -0.00
- LPCN -0.10
- Stochastic Oscillator
- GP 20.09
- LPCN 24.06
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.